USA
News & Media
Take a closer look at what we’re doing across Teva worldwide
Press releases
Jul 15 / 2019
Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder
The First Digital Maintenance Asthma Inhaler Therapy with Integrated Sensors Joins Teva’s Digital Rescue Inhaler Therapy to Provide Patients with Technology to Track Treatment Use
Jul 11 / 2019
Teva Completes Facilities Purchase in Pennsylvania for North America Research & Development Campus
Jul 10 / 2019
Teva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection at the American Headache Society’s 61st Annual Scientific Meeting
Three late breakers, one oral presentation and 27 posters showcase AJOVY as a preventive treatment for migraine
Jul 3 / 2019
Teva to Host Conference Call to Discuss Second Quarter 2019 Financial Results at 8 a.m. ET on August 7, 2019
Top Stories
Read the latest Teva news
18 Jul 2019
Meet the Expert: Corey Sparks
Corey Sparks, VP of Finance and Controller of North America talks about what it's like to work at Teva.
11 Jul 2019
Social Impact at Teva—2018 Progress and More: A Conversation with Amalia Adler-Waxman
Social Impact at Teva—2018 Progress and More: A Conversation with Amalia Adler-Waxman, Vice President, Social Impact & Responsibility.
21 Jun 2019
Celebrating Pride Month At Teva
Teva’s Pride Employee Resource (ERG) group members reflect on the role the Stonewall Uprising played in their own lives and the important mission of the ERG for fostering a culture of inclusion.
